Tordesillas, Leticia
Lozano-Ojalvo, Daniel
Dunkin, David
Mondoulet, Lucie
Agudo, Judith
Merad, Miriam
Sampson, Hugh A.
Berin, M. Cecilia
Article History
Received: 16 January 2018
Accepted: 21 November 2018
First Online: 7 December 2018
Competing interests
: L.M. and H.A.S. are employed by DBV Technologies, the maker of the Viaskin Patch used to deliver topical antigen in this manuscript. D.D. has received research support from DBV Technologies. The remaining authors declare no competing interests.